Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-HPV-nonavalent-vaccine below:

Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine

Placeholder slot

(ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus NOH-nuh-VAY-lent vak-SEEN)

The HPV nonavalent vaccine protects against infection with low-risk HPV types 6 and 11, which cause most genital warts, and against high-risk HPV types 16, 18, 31, 33, 45, 52, and 58, which cause several types of precancers and cancer.

US Brand Name(s)

Gardasil 9

FDA label information for this drug is available at DailyMed.

The HPV nonavalent vaccine is used in individuals aged 9 to 45 years to prevent:

• Anal cancer.
• Cervical cancer.
• Head and neck cancer, including oropharyngeal cancer.¹
• Vaginal cancer.
• Vulvar cancer.
• Lesions that sometimes lead to anal, cervical, vaginal, or vulvar cancer.
• Genital warts.

¹This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that recombinant human papillomavirus (HPV) nonavalent vaccine provides a clinical benefit in these patients.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

More Evidence that One HPV Vaccine Dose Protects against Cancer-Causing Infections

HPV and Cancer

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

Human Papillomavirus (HPV) Vaccines

Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types

HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections

The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool

Find Clinical Trials for Recombinant Human Papillomavirus Nonavalent Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3